Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00861679
What this trial is testing

Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International

Who this might be right for
Acute Lymphoblastic Leukemia
Hadassah Medical Organization 552
Testing effectiveness (Phase 2)Study completedNCT01572662
What this trial is testing

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Who this might be right for
LeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+7 more
M.D. Anderson Cancer Center 201
Testing effectiveness (Phase 2)WithdrawnNCT00874315
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Who this might be right for
Neuroblastoma
Nationwide Children's Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829952
What this trial is testing

Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Henan University of Science and Technology 87
Testing effectiveness (Phase 2)Study completedNCT00044733
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer 38
Early research (Phase 1)Ended earlyNCT02846376
What this trial is testing

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hackensack Meridian Health 8
Early research (Phase 1)UnknownNCT05127135
What this trial is testing

Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Who this might be right for
T-Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin LymphomaT-cell Acute Lymphoblastic Lymphoma
Fundamenta Therapeutics, Ltd. 30
Not applicableStudy completedNCT01766934
What this trial is testing

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Who this might be right for
Hematopoietic Stem Cell Mobilization
Sandoz 245
Early research (Phase 1)Active Not RecruitingNCT07094464
What this trial is testing

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Who this might be right for
TP53-mutated MDS and AMLAllogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu 20
Not applicableEnded earlyNCT00658411
What this trial is testing

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 5
Not applicableStudy completedNCT03202849
What this trial is testing

Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplant
Children's Hospital Medical Center, Cincinnati 83
Testing effectiveness (Phase 2)Ended earlyNCT00003552
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT03270748
What this trial is testing

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Gruppo Italiano Trapianto di Midollo Osseo 78
Early research (Phase 1)UnknownNCT04886206
What this trial is testing

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML)
Nantes University Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01475058
What this trial is testing

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

Who this might be right for
Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+4 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05682755
What this trial is testing

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, Acute
Sichuan University 77
Testing effectiveness (Phase 2)UnknownNCT04632316
What this trial is testing

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Glycostem Therapeutics BV 33
Testing effectiveness (Phase 2)Ended earlyNCT02259348
What this trial is testing

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT03343600
What this trial is testing

Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 5
Not applicableLooking for participantsNCT06702111
What this trial is testing

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplant (HSCT)
The University of Hong Kong 1,000
Next Page